New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Unique cancer drug discovered with help from Advanced Light Source begins historical clinical trial

Unique cancer drug discovered with help from Advanced Light Source begins historical clinical trial

by Aliyah Kovner,Lawrence Berkeley National LaboratoryA structural map of KRAS(G12C), showing the AMG 510 molecule in the binding pocket. Amgen is a Participating Research Team member of the Ber
Oncology December 22,2023
Unique cancer drug discovered with help from Advanced Light Source begins historical clinical trial

Unique cancer drug discovered with help from Advanced Light Source begins historical clinical trial

by Aliyah Kovner,Lawrence Berkeley National LaboratoryA structural map of KRAS(G12C), showing the AMG 510 molecule in the binding pocket. Amgen is a Participating Research Team member of the Ber
Oncology December 22,2023
'Cure or nothing' doesn't capture the realities of modern cancer research and treatment

'Cure or nothing' doesn't capture the realities of modern cancer research and treatment

by Paul Workman,Institute of Cancer ResearchAbiraterone was the first treatment shown to be effective in men with advanced prostate cancer. Credit: Institute of Cancer ResearchCancer was in the
Oncology December 22,2023
'Cure or nothing' doesn't capture the realities of modern cancer research and treatment

'Cure or nothing' doesn't capture the realities of modern cancer research and treatment

by Paul Workman,Institute of Cancer ResearchAbiraterone was the first treatment shown to be effective in men with advanced prostate cancer. Credit: Institute of Cancer ResearchCancer was in the
Oncology December 22,2023
Finding a non-invasive way to predict effectiveness of cancer therapy

Finding a non-invasive way to predict effectiveness of cancer therapy

by Society of Nuclear Medicine and Molecular ImagingBiodistribution of 89Zr-labeled mAb: physiologic components. (A) Reversible nonspecific uptake due to antibody in vascular tissue compartment and an
Oncology December 22,2023
Finding a non-invasive way to predict effectiveness of cancer therapy

Finding a non-invasive way to predict effectiveness of cancer therapy

by Society of Nuclear Medicine and Molecular ImagingBiodistribution of 89Zr-labeled mAb: physiologic components. (A) Reversible nonspecific uptake due to antibody in vascular tissue compartment and an
Oncology December 22,2023
New model explains how our immune system sometimes helps cancer spread

New model explains how our immune system sometimes helps cancer spread

by Katie Willis,University of AlbertaCredit: CC0 Public DomainMathematicians at the University of Alberta have developed a model that explains how the immune system interacts with cancer—and in
Oncology December 22,2023
New model explains how our immune system sometimes helps cancer spread

New model explains how our immune system sometimes helps cancer spread

by Katie Willis,University of AlbertaCredit: CC0 Public DomainMathematicians at the University of Alberta have developed a model that explains how the immune system interacts with cancer—and in
Oncology December 22,2023
Residual cancer burden after neoadjuvant therapy can accurately predict breast cancer survival

Residual cancer burden after neoadjuvant therapy can accurately predict breast cancer survival

byUniversity of Texas M. D. Anderson Cancer CenterW. Fraser Symmans, M.D. Credit: MD Anderson Cancer CenterResearchers from The University of Texas MD Anderson Cancer Center today reported resul
Oncology December 22,2023
Residual cancer burden after neoadjuvant therapy can accurately predict breast cancer survival

Residual cancer burden after neoadjuvant therapy can accurately predict breast cancer survival

byUniversity of Texas M. D. Anderson Cancer CenterW. Fraser Symmans, M.D. Credit: MD Anderson Cancer CenterResearchers from The University of Texas MD Anderson Cancer Center today reported resul
Oncology December 22,2023
Novel genetic signature that can predict some kinds of breast cancer is identified

Novel genetic signature that can predict some kinds of breast cancer is identified

by Maria Fernanda Ziegler,FAPESPBlood vessels from the retina of a mouse with retinopathy, normal and pathological vessels stained green and red respectively. Credit: Ricardo GiordanoResearchers
Oncology December 22,2023
Novel genetic signature that can predict some kinds of breast cancer is identified

Novel genetic signature that can predict some kinds of breast cancer is identified

by Maria Fernanda Ziegler,FAPESPBlood vessels from the retina of a mouse with retinopathy, normal and pathological vessels stained green and red respectively. Credit: Ricardo GiordanoResearchers
Oncology December 22,2023
Saccharin derivatives give cancer cells a not-so-sweet surprise

Saccharin derivatives give cancer cells a not-so-sweet surprise

byAmerican Chemical SocietyCredit: American Chemical SocietySaccharin received a bad rap after studies in the 1970s linked consumption of large amounts of the artificial sweetener to bladder can
Oncology December 22,2023
Saccharin derivatives give cancer cells a not-so-sweet surprise

Saccharin derivatives give cancer cells a not-so-sweet surprise

byAmerican Chemical SocietyCredit: American Chemical SocietySaccharin received a bad rap after studies in the 1970s linked consumption of large amounts of the artificial sweetener to bladder can
Oncology December 22,2023
Rapid tissue donation program offers feasible approach to improve research

Rapid tissue donation program offers feasible approach to improve research

byH. Lee Moffitt Cancer Center & Research InstituteCredit: CC0 Public DomainPrecision medicine with targeted therapies has led to improved treatment options and patient outcomes. These appro
World medicine December 22,2023
Rapid tissue donation program offers feasible approach to improve research

Rapid tissue donation program offers feasible approach to improve research

byH. Lee Moffitt Cancer Center & Research InstituteCredit: CC0 Public DomainPrecision medicine with targeted therapies has led to improved treatment options and patient outcomes. These appro
World medicine December 22,2023
Scientists identify potential drug target for BRCA-mutated tumours

Scientists identify potential drug target for BRCA-mutated tumours

byInstitute of Cancer ResearchCrystal structure of EXD2 exonuclease domain in spacefill format. Credit: Image generated fromPDBA new study has uncovered a previously unknown role for the e
Oncology December 22,2023
Scientists identify potential drug target for BRCA-mutated tumours

Scientists identify potential drug target for BRCA-mutated tumours

byInstitute of Cancer ResearchCrystal structure of EXD2 exonuclease domain in spacefill format. Credit: Image generated fromPDBA new study has uncovered a previously unknown role for the e
Oncology December 22,2023
Artificial intelligence tracks down leukemia

Artificial intelligence tracks down leukemia

byGerman Center for Neurodegenerative DiseasesCredit: CC0 Public DomainArtificial intelligence can detect one of the most common forms of blood cancer—acute myeloid leukemia (AML)—with high reli
Oncology December 22,2023
Artificial intelligence tracks down leukemia

Artificial intelligence tracks down leukemia

byGerman Center for Neurodegenerative DiseasesCredit: CC0 Public DomainArtificial intelligence can detect one of the most common forms of blood cancer—acute myeloid leukemia (AML)—with high reli
Oncology December 22,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com